Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Dosing began at 0.25 mg of each active drug and escalated every four weeks until the full 2.4 mg dose was reached by week 16
It has been reported that IGFBP-3 binds to a nuclear receptor, 9-cis retinoic acid receptor-alpha (RXR-), which interacts with peroxisome proliferator activated receptor-gamma (PPAR-), a nuclear protein involved in the regulation of glucose and lipid metabolism [175, 176]
Quality documentation includes a Certificate of Analysis (COA) for every production batch, providing full analytical transparency
Sourced with 99% purity and validated via HPLC analysis, this 100mg formulation is ideal for in vitro and preclinical studies in controlled research environments
Our wholesale model supports customers seeking: Bulk BPC-157 orders Recurring supply programs Laboratory procurement solutions Research inventory management Long-term wholesale partnerships Reliable domestic fulfillment Rather than taking a one-size-fits-all approach, we work to support the unique purchasing requirements of each customer, whether they require moderate inventory levels or large-volume supply arrangements
US$ 23.22
US$ 27.17
US$ 20.37
US$ 23.24
US$ 24.22
